BMI1 and non-small cell lung carcinoma: These results highlight the potential of using a combination of SOX4 and BMI1 to improve the accuracy of prognostic predictions in NSCLC patients, suggesting a potential joint role of SOX4 and BMI1 in the progression and prognosis of NSCLC.